Clinical Trial Update: Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial updating cholecalciferol supplementation in restless leg syndrome patients with chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adynamic Bone Disease
• Chronic Kidney Disease
• Hyperparathyroidism Secondary
• Restless Leg Syndrome
• Vitamin Deficiency

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Restless Leg Disorder, Renal Disease Bone | Phase 4 | Status: WITHDRAWN